Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function

被引：0
|
作者：
Spinale, FG
Krombach, RS
Coker, ML
Mukherjee, R
Houck, WV
Clair, MJ
Kribbs, SB
Hebbar, L
Peterson, JT
机构：
[1] MED UNIV S CAROLINA,CHARLESTON,SC 29425
[2] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,ANN ARBOR,MI 48105
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2915 / 2915
页数：1
相关论文
共 50 条
  • [1] Matrix metalloproteinase inhibition during the development of congestive heart failure - Effects on left ventricular dimensions and function
    Spinale, FG
    Coker, ML
    Krombach, SR
    Mukherjee, R
    Hallak, H
    Houck, WV
    Clair, MJ
    Kribbs, SB
    Johnson, LL
    Peterson, JT
    Zile, MR
    [J]. CIRCULATION RESEARCH, 1999, 85 (04) : 364 - 376
  • [2] Selective matrix metalloproteinase inhibition influences LV function and geometry with developing congestive heart failure
    King, MK
    Coker, ML
    Goldberg, AT
    Morrison, AE
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Wendt, KA
    O'Neill, TP
    Zile, MR
    Spinale, FG
    [J]. CIRCULATION, 2000, 102 (18) : 452 - 452
  • [3] Combined angiotensin converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Effects on left ventricular function and geometry
    Spinale, FG
    McElmurray, JH
    Mukherjee, R
    New, BR
    Sampson, AC
    King, MK
    Hendrick, JW
    Patterson, TM
    Peterson, JT
    Zile, MR
    [J]. CIRCULATION, 1999, 100 (18) : 647 - 647
  • [4] Selective matrix metalloproteinase inhibition with developing heart failure - Effects on left ventricular function and structure
    King, MK
    Coker, ML
    Goldberg, A
    McElmurray, JH
    Gunasinghe, HR
    Mukherjee, R
    Zile, MR
    O'Neill, TP
    Spinale, FG
    [J]. CIRCULATION RESEARCH, 2003, 92 (02) : 177 - 185
  • [5] Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Comparative effects on left ventricular function and geometry
    McElmurray, JH
    Mukherjee, R
    New, RB
    Sampson, AC
    King, MK
    Hendrick, JW
    Goldberg, A
    Peterson, TJ
    Hallak, H
    Zile, MR
    Spinale, FG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 799 - 811
  • [6] Simvastatin improves survival and left ventricular function in the setting of congestive heart failure
    Kakkar, AK
    Greeer, JJ
    Jones, SP
    Hicks, MR
    Lefer, DJ
    [J]. CIRCULATION, 2003, 108 (17) : 146 - 147
  • [7] Matrix metalloproteinase in left ventricular remodeling and heart failure
    Suresh Shastry
    Melvin R. Hayden
    Pamela A. Lucchesi
    Suresh C. Tyagi
    [J]. Current Cardiology Reports, 2003, 5 (3) : 200 - 204
  • [8] Selective matrix metalloproteinase inhibition influences LV geometry and myocardial structure in developing congestive heart failure
    O'Neill, TP
    King, MK
    Coker, ML
    Goldberg, AT
    Morrison, AE
    Holder, JR
    Gunasinghe, HR
    Mukherjee, R
    Wendt, KA
    Zile, MR
    Spinale, FG
    [J]. CIRCULATION, 2000, 102 (18) : 292 - 292
  • [9] Congestive heart failure with Normal left ventricular systolic function
    Preobrazhensky, DV
    Sidorenko, BA
    Shatunova, IM
    Aleksandrova, AU
    [J]. KARDIOLOGIYA, 2001, 41 (01) : 85 - 91
  • [10] Differential regulation of matrix metalloproteinase 9 in heart failure with and without preserved left ventricular function
    Reinhardt, D
    Laetz, M
    Sigusch, HH
    Figulla, HR
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 505 - 505
12345